Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 | Zendy

Jerald Sadoff | Zendy; Glenda Gray | Zendy; An Vandebosch | Zendy; Vicky Cárdenas | Zendy; Georgi Shukarev | Zendy; Beatriz Grinsztejn | Zendy; Paul Goepfert | Zendy; Carla Truyers | Zendy; Hein Fennema | Zendy; Bart Spiessens | Zendy; Kim Offergeld | Zendy; Gert C. Scheper | Zendy; Kimberly L. Taylor | Zendy; Merlin L. Robb | Zendy; John J. Treanor | Zendy; Dan H. Barouch | Zendy; Jeffrey J. Stoddard | Zendy; Martin Ryser | Zendy; Mary Marovich | Zendy; Kathleen M. Neuzil | Zendy; Lawrence Corey | Zendy; Nancy Cauwenberghs | Zendy; Tamzin Tanner | Zendy; Karin Hardt | Zendy; Javier RuizGuiñazú | Zendy; Mathieu Le Gars | Zendy; Hanneke Schuitemaker | Zendy; Johan Van Hoof | Zendy; Frank Struyf | Zendy; Macaya Douoguih | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Author(s) -

Jerald Sadoff,

Glenda Gray,

An Vandebosch,

Vicky Cárdenas,

Georgi Shukarev,

Beatriz Grinsztejn,

Paul Goepfert,

Carla Truyers,

Hein Fennema,

Bart Spiessens,

Kim Offergeld,

Gert C. Scheper,

Kimberly L. Taylor,

Merlin L. Robb,

John J. Treanor,

Dan H. Barouch,

Jeffrey J. Stoddard,

Martin Ryser,

Mary Marovich,

Kathleen M. Neuzil,

Lawrence Corey,

Nancy Cauwenberghs,

Tamzin Tanner,

Karin Hardt,

Javier RuizGuiñazú,

Mathieu Le Gars,

Hanneke Schuitemaker,

Johan Van Hoof,

Frank Struyf,

Macaya Douoguih

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2101544

Subject(s) - medicine , placebo , confidence interval , population , vaccine efficacy , randomized controlled trial , gastroenterology , immunology , vaccination , pathology , alternative medicine , environmental health

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research